Use of Linked Nordic Registries for Population Studies in Hematologic Cancers: The Case of Multiple Myeloma

References

• Frank L. Epidemiology when an entire country is a cohort. Science. 2000;287(5462):2398–2399. doi:10.1126/science.287.5462.2398
   PubMed Web of Science ®Google Scholar
• Thygesen LC, Ersbøll AK. When the entire population is the sample: strengths and limitations in register-based epidemiology. Eur J Epidemiol. 2014;29(8):551–558. doi:10.1007/s10654-013-9873-0
   PubMed Web of Science ®Google Scholar
• Forsea AM. Cancer registries in Europe-going forward is the only option. Ecancermedicalscience. 2016;10:641. doi:10.3332/ecancer.2016.641
   PubMedGoogle Scholar
• Zanetti R, Sacchetto L, Coebergh JW, Rosso S. To accelerate cancer prevention in Europe: challenges for cancer registries. Eur J Cancer. 2018;104:151–159. doi:10.1016/j.ejca.2018.09.001
   PubMed Web of Science ®Google Scholar
• Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, Sørensen HT. The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol. 2010;106(2):86–94. doi:10.1111/j.1742-7843.2009.00494.x
   PubMed Web of Science ®Google Scholar
• Thygesen LC, Daasnes C, Thaulow I, Brønnum-Hansen H. Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving. Scand J Public Health. 2011;39(7 Suppl):12–16. doi:10.1177/1403494811399956
   PubMed Web of Science ®Google Scholar
• Van Der Wel KA, Östergren O, Lundberg O, et al. A gold mine, but still no Klondike: Nordic register data in health inequalities research. Scand J Public Health. 2019;47(6):618–630. doi:10.1177/1403494819858046
   PubMed Web of Science ®Google Scholar
• Maret-Ouda J, Tao W, Wahlin K, Lagergren J. Nordic registry-based cohort studies: possibilities and pitfalls when combining Nordic registry data. Scand J Public Health. 2017;45(17_suppl):14–19. doi:10.1177/1403494817702336
   PubMed Web of Science ®Google Scholar
• Laugesen K, Ludvigsson JF, Schmidt M, et al. Nordic health registry-based research: a review of health care systems and key registries. Clin Epidemiol. 2021;13:533–554. doi:10.2147/CLEP.S314959
   PubMed Web of Science ®Google Scholar
• Nilbert M, Thomsen LA, Winther Jensen J, et al. The power of empirical data; lessons from the clinical registry initiatives in Scandinavian cancer care. Acta Oncol. 2020;59(11):1343–1356. doi:10.1080/0284186x.2020.1820573
   PubMed Web of Science ®Google Scholar
• Pukkala E, Engholm G, Højsgaard Schmidt LK, et al. Nordic cancer registries - an overview of their procedures and data comparability. Acta Oncol. 2018;57(4):440–455. doi:10.1080/0284186x.2017.1407039
   PubMed Web of Science ®Google Scholar
• Wettermark B, Zoëga H, Furu K, et al. The Nordic prescription databases as a resource for pharmacoepidemiological research--a literature review. Pharmacoepidemiol Drug Saf. 2013;22(7):691–699. doi:10.1002/pds.3457
   PubMed Web of Science ®Google Scholar
• Gavin A, Rous B, Marcos-Gragera R, et al. Towards optimal clinical and epidemiological registration of haematological malignancies: guidelines for recording progressions, transformations and multiple diagnoses. Eur J Cancer. 2015;51(9):1109–1122. doi:10.1016/j.ejca.2014.02.008
   PubMed Web of Science ®Google Scholar
• Leinonen MK, Rantanen M, Pitkäniemi J, Malila N. Coverage and accuracy of myeloproliferative and myelodysplastic neoplasms in the Finnish Cancer Registry. Acta Oncol. 2016;55(6):782–786. doi:10.3109/0284186x.2015.1127416
   PubMed Web of Science ®Google Scholar
• Castella M, Fernández de Larrea C, Martín-Antonio B. Immunotherapy: a novel era of promising treatments for multiple myeloma. Int J Mol Sci. 2018;19(11):3613. doi:10.3390/ijms19113613
   PubMed Web of Science ®Google Scholar
• Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538–548. doi:10.1016/s1470-2045(14)70442-5
   PubMed Web of Science ®Google Scholar
• Cowan AJ, Allen C, Barac A, et al. Global burden of multiple myeloma: a systematic analysis for the global burden of disease study 2016. JAMA Oncol. 2018;4(9):1221–1227. doi:10.1001/jamaoncol.2018.2128
   PubMed Web of Science ®Google Scholar
• Danish Health Data Authority. National patient register. Available from: https://sundhedsdatastyrelsen.dk/da/registre-og-services/om-de-nationale-sundhedsregistre/sygdomme-laegemidler-og-behandlinger/landspatientregisteret. Accessed March 6, 2023.
   Google Scholar
• Finnish Institute for Health and Welfare (THL). Finnish national care register for healthcare institutions (HILMO). Available from: https://thl.fi/en/web/thlfi-en/statistics-and-data/data-and-services/register-descriptions/care-register-for-health-care. Accessed March 6, 2023.
   Google Scholar
• Finnish Institute for Health and Welfare (THL). Primary health care outpatient care notification (AvoHILMO). Available from: https://thl.fi/fi/tilastot-ja-data/ohjeet-tietojen-toimittamiseen/perusterveydenhuollon-avohoidon-hoitoilmoitus-avohilmo. Accessed March 6, 2023.
   Google Scholar
• The National Board of Health and Welfare, Sweden. National patient register. Available from: https://www.socialstyrelsen.se/en/statistics-and-data/registers/national-patient-register/. Accessed March 6, 2023.
   Google Scholar
• Danish Health Data Authority. Medicines statistics register. Available from: https://sundhedsdatastyrelsen.dk/da/registre-og-services/om-de-nationale-sundhedsregistre/sygdomme-laegemidler-og-behandlinger/laegemiddelstatistikregisteret. Accessed March 7, 2023.
   Google Scholar
• Kela. Deliveries of medicines reimbursed by health insurance. Available from: https://www.stat.fi/tilasto/resep. Accessed March 7, 2023.
   Google Scholar
• The National Board of Health and Welfare, Sweden. National prescribed drug register. Available from: https://www.socialstyrelsen.se/en/statistics-and-data/registers/national-prescribed-drug-register/. Accessed March 7, 2023.
   Google Scholar
• Danish Health Data Authority. Cancer registry. Available from: https://sundhedsdatastyrelsen.dk/da/registre-og-services/om-de-nationale-sundhedsregistre/sygdomme-laegemidler-og-behandlinger/cancerregisteret. Accessed March 7, 2023.
   Google Scholar
• Cancer Society of Finland. Finnish cancer registry. Available from: https://syoparekisteri.fi/. Accessed March 7, 2023.
   Google Scholar
• The National Board of Health and Welfare, Sweden. National cancer register. Available from: https://www.socialstyrelsen.se/en/statistics-and-data/registers/national-cancer-register/. Accessed March 7, 2023.
   Google Scholar
• Leinonen MK, Miettinen J, Heikkinen S, Pitkäniemi J, Malila N. Quality measures of the population-based Finnish cancer registry indicate sound data quality for solid malignant tumours. Eur J Cancer. 2017;77:31–39. doi:10.1016/j.ejca.2017.02.017
   PubMed Web of Science ®Google Scholar
• Sund R. Quality of the Finnish Hospital Discharge Register: a systematic review. Scand J Public Health. 2012;40(6):505–515. doi:10.1177/1403494812456637
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Håberg SE, Knudsen GP, et al. Ethical aspects of registry-based research in the Nordic countries. Clin Epidemiol. 2015;7:491–508. doi:10.2147/clep.S90589
   PubMed Web of Science ®Google Scholar
• Gimsing P, Holmström MO, Klausen TW, et al. The Danish National Multiple Myeloma Registry. Clin Epidemiol. 2016;8:583–587. doi:10.2147/clep.S99463
   PubMed Web of Science ®Google Scholar
• Blimark CH, Turesson I, Genell A, et al. Outcome and survival of myeloma patients diagnosed 2008–2015. Real-world data on 4904 patients from the Swedish Myeloma Registry. Haematologica. 2018;103(3):506–513. doi:10.3324/haematol.2017.178103
   PubMed Web of Science ®Google Scholar
• Regional Cancer Centres Samverkan. Individuell patientöversikt (IPÖ) i cancervården [Individual patient overview (IPÖ) in cancer care]. Swedish. Available from: https://cancercentrum.se/samverkan/vara-uppdrag/kunskapsstyrning/patientoversikter/. Accessed June 28, 2023.
   Google Scholar
• Vélez R, Turesson I, Landgren O, Kristinsson SY, Cuzick J. Incidence of multiple myeloma in Great Britain, Sweden, and Malmö, Sweden: the impact of differences in case ascertainment on observed incidence trends. BMJ Open. 2016;6(1):e009584. doi:10.1136/bmjopen-2015-009584
   PubMed Web of Science ®Google Scholar
• Pitkäniemi J, Malila N, Tanskanen T, et al. Cancer in Finland 2018. Cancer Soc Finland Pub. 2018;2018:98.
   Google Scholar
• Hannig LH, Nielsen LK, Ibsen R, Arnheim-Dahlstrom L, Kjellberg J, Abildgaard N. The impact of changed treatment patterns in multiple myeloma on health-care utilisation and costs, myeloma complications, and survival: a population-based comparison between two time periods in Denmark. Eur J Haematol. 2021;107(1):63–73. doi:10.1111/ejh.13615
   PubMed Web of Science ®Google Scholar
• Borgsten F, Gatopoulou X, Pisini M, et al. Healthcare resource utilisation and sickness absence in newly diagnosed multiple myeloma patients who did not undergo autologous stem cell transplantation: trends in Sweden with the changing treatment landscape. Eur J Haematol. 2021;107(1):92–103. doi:10.1111/ejh.13623
   PubMed Web of Science ®Google Scholar
• Langseth ØO, Myklebust T, Johannesen TB, Hjertner Ø, Waage A. Incidence and survival of multiple myeloma: a population-based study of 10 524 patients diagnosed 1982–2017. Br J Haematol. 2020;191(3):418–425. doi:10.1111/bjh.16674
   PubMed Web of Science ®Google Scholar